miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation

Wei Zhang, Jo Hsin Chen, Tianjiao Shan, Irene Aguilera-Barrantes, Li Shu Wang, Tim Hui Ming Huang, Janet S. Rader, Xiugui Sheng, Yi Wen Huang

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Endometrial cancer is the most common gynecological cancer in the United States. We wanted to identify epigenetic aberrations involving microRNAs (miRNAs), whose genes become hypermethylated in endometrial primary tumors. By integrating known miRNA sequences from the miRNA database (miRBase) with DNA methylation data from methyl-CpG-capture sequencing, we identified 111 differentially methylated regions (DMRs) associated with CpG islands (CGIs) and miRNAs. Among them, 22 DMRs related to 29 miRNAs and within 8 kb of CGIs were hypermethylated in endometrial tumors but not in normal endometrium. miR-137 was further validated in additional endometrial primary tumors. Hypermethylation of miR-137 was found in both endometrioid and serous endometrial cancer (P < 0.01), and it led to the loss of miR-137 expression. Treating hypermethylated endometrial cancer cells with epigenetic inhibitors reactivated miR-137. Moreover, genetic overexpression of miR-137 suppressed cancer cell proliferation and colony formation in vitro. When transfected cancer cells were implanted into nude mice, the cells that overexpressed miR-137 grew more slowly and formed smaller tumors (P < 0.05) than vector transfectants. Histologically, xenograft tumors from cancer cells expressing miR-137 were less proliferative (P < 0.05), partly due to inhibition of EZH2 and LSD1 expression (P < 0.01) in both the transfected cancer cells and tumors. Reporter assays indicated that miR-137 targets EZH2 and LSD1. These results suggest that miR-137 is a tumor suppressor that is repressed in endometrial cancer because the promoter of its gene becomes hypermethylated.

Original languageEnglish (US)
Pages (from-to)1397-1407
Number of pages11
JournalLaboratory Investigation
Volume98
Issue number11
DOIs
StatePublished - Nov 1 2018

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation'. Together they form a unique fingerprint.

  • Cite this

    Zhang, W., Chen, J. H., Shan, T., Aguilera-Barrantes, I., Wang, L. S., Huang, T. H. M., Rader, J. S., Sheng, X., & Huang, Y. W. (2018). miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation. Laboratory Investigation, 98(11), 1397-1407. https://doi.org/10.1038/s41374-018-0092-x